share_log

Forecasting The Future: 9 Analyst Projections For Capricor Therapeutics

Forecasting The Future: 9 Analyst Projections For Capricor Therapeutics

預測未來:9位分析師對capricor therapeutics的預測
Benzinga ·  03:01
Throughout the last three months, 9 analysts have evaluated Capricor Therapeutics (NASDAQ:CAPR), offering a diverse set of opinions from bullish to bearish.
在過去的三個月裏,9位分析師對capricor therapeutics (納斯達克:CAPR) 進行了評估,提供了從看好到看淡的多樣化意見。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級,展示了過去30天內不斷變化的情緒,並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.44, a high estimate of $43.00, and a low estimate of $8.00. This upward trend is apparent, with the current average reflecting a 21.4% increase from the previous average price target of $21.78.
分析師通過對12個月價格目標的評估提供了更深入的見解,揭示了平均目標爲26.44美元,最高預估爲43.00美元,最低預估爲8.00美元。這一上升趨勢明顯,當前平均數反映了相比上一次21.78美元的平均價格目標增長了21.4%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
The analysis of recent analyst actions...
最近分析師行...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論